Genmab A/S Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio12.0932.3535.2658.1933.86
P/S Ratio4.408.5413.2520.4415.93
P/B Ratio2.584.457.057.758.43
Price/Tangible Book4.344.477.087.848.58
Price/FCF12.5020.0753.4787.0826.30
Price/OCF12.2019.0749.1477.2325.04
Enterprise Value Ratios
EV/Revenue3.656.9211.6618.2714.24
EV/EBITDA10.6220.6325.7948.8622.00
EV/EBIT11.0921.4326.9852.0722.81
EV/FCF10.3516.2647.0377.8123.50
Profitability & Returns
Return on Equity (ROE)0.23%0.15%0.22%0.14%0.29%
Return on Assets (ROA)0.11%0.10%0.14%0.08%0.22%
Return on Invested Capital (ROIC)0.57%0.85%1.09%0.65%1.61%
Return on Capital Employed (ROCE)0.17%0.16%0.22%0.13%0.32%
Leverage & Solvency Ratios
Debt/Equity0.030.020.020.020.02
Debt/EBITDA0.140.140.090.140.05
Debt/FCF0.140.110.170.210.05
Liquidity Ratios
Current Ratio5.2513.3415.4814.5015.00
Quick Ratio5.2413.3215.4814.5015.00
Efficiency Ratios
Asset Turnover0.530.500.530.370.56
Inventory Turnover16.55
Yield & Distribution Ratios
Earnings Yield0.08%0.03%0.03%0.02%0.03%
FCF Yield0.08%0.05%0.02%0.01%0.04%
Buyback Yield0.02%0.00%0.00%0.00%-0.04%